Literature DB >> 29884099

External validation of change formulae in neuropsychology with neuroimaging biomarkers: A methodological recommendation and preliminary clinical data.

Kevin Duff1, Kayla R Suhrie1, Bonnie C A Dalley1, Jeffrey S Anderson2, John M Hoffman2,3.   

Abstract

OBJECTIVE: Within neuropsychology, a number of mathematical formulae (e.g. reliable change index, standardized regression based) have been used to determine if change across time has reliably occurred. When these formulae have been compared, they often produce different results, but 'different' results do not necessarily indicate which formulae are 'best.' The current study sought to further our understanding of change formulae by comparing them to clinically relevant external criteria (amyloid deposition and hippocampal volume).
METHOD: In a sample of 25 older adults with varying levels of cognitive intactness, participants were tested twice across one week with a brief cognitive battery. Seven different change scores were calculated for each participant. An amyloid PET scan (to get a composite of amyloid deposition) and an MRI (to get hippocampal volume) were also obtained.
RESULTS: Deviation-based change formulae (e.g. simple discrepancy score, reliable change index with or without correction for practice effects) were all identical in their relationship to the two neuroimaging biomarkers, and all were non-significant. Conversely, regression-based change formulae (e.g. simple and complex indices) showed stronger relationships to amyloid deposition and hippocampal volume.
CONCLUSIONS: These results highlight the need for external validation of the various change formulae used by neuropsychologists in clinical settings and research projects. The findings also preliminarily suggest that regression-based change formulae may be more relevant than deviation-based change formulae in this context.

Entities:  

Keywords:  Alzheimer’s disease; Cognitive change; biomarkers

Mesh:

Substances:

Year:  2018        PMID: 29884099      PMCID: PMC6298853          DOI: 10.1080/13854046.2018.1484518

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  36 in total

Review 1.  Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods.

Authors:  Kevin Duff
Journal:  Arch Clin Neuropsychol       Date:  2012-02-29       Impact factor: 2.813

2.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.

Authors:  N S Jacobson; P Truax
Journal:  J Consult Clin Psychol       Date:  1991-02

3.  Reliable change and practice effects: outcomes of various indices compared.

Authors:  Gerard H Maassen; Ercolie Bossema; Nico Brand
Journal:  J Clin Exp Neuropsychol       Date:  2008-07-11       Impact factor: 2.475

4.  Clarifying Discrepancies in Responsiveness Between Reliable Change Indices.

Authors:  Anton D Hinton-Bayre
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

5.  [Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status.

Authors:  Mary M Machulda; Clint E Hagen; Heather J Wiste; Michelle M Mielke; David S Knopman; Rosebud O Roberts; Prashanthi Vemuri; Val J Lowe; Clifford R Jack; Ronald C Petersen
Journal:  Clin Neuropsychol       Date:  2016-10-11       Impact factor: 3.535

6.  Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models.

Authors:  L A Ouimet; A Stewart; B Collins; D Schindler; C Bielajew
Journal:  J Clin Exp Neuropsychol       Date:  2008-06-03       Impact factor: 2.475

7.  The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts.

Authors:  Andrew J Levine; Charles H Hinkin; Eric N Miller; James T Becker; Ola A Selnes; Bruce A Cohen
Journal:  J Clin Exp Neuropsychol       Date:  2007-08       Impact factor: 2.475

8.  Short-Term Practice Effects and Amyloid Deposition: Providing Information Above and Beyond Baseline Cognition.

Authors:  K Duff; D B Hammers; B C A Dalley; K R Suhrie; T J Atkinson; K M Rasmussen; K P Horn; B E Beardmore; L D Burrell; N L Foster; J M Hoffman
Journal:  J Prev Alzheimers Dis       Date:  2017

9.  Norms for change in episodic memory as a prerequisite for the diagnosis of mild cognitive impairment (MCI).

Authors:  Stefan Bläsi; Antoinette E Zehnder; Manfred Berres; Kirsten I Taylor; René Spiegel; Andreas U Monsch
Journal:  Neuropsychology       Date:  2009-03       Impact factor: 3.295

Review 10.  A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Howard H Feldman; Giovanni B Frisoni; Harald Hampel; William J Jagust; Keith A Johnson; David S Knopman; Ronald C Petersen; Philip Scheltens; Reisa A Sperling; Bruno Dubois
Journal:  Neurology       Date:  2016-07-01       Impact factor: 9.910

View more
  3 in total

1.  Rationale and Design of the National Neuropsychology Network.

Authors:  David W Loring; Russell M Bauer; Lucia Cavanagh; Daniel L Drane; Laura Glass Umfleet; Dustin Wahlstrom; Fiona Whelan; Keith F Widaman; Robert M Bilder; Kristen D Enriquez; Steven P Reise; KuoChung Shih
Journal:  J Int Neuropsychol Soc       Date:  2021-03-04       Impact factor: 2.892

2.  Dynamic modeling of practice effects across the healthy aging-Alzheimer's disease continuum.

Authors:  Andrew R Bender; Arkaprabha Ganguli; Melinda Meiring; Benjamin M Hampstead; Charles C Driver
Journal:  Front Aging Neurosci       Date:  2022-07-28       Impact factor: 5.702

3.  A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.

Authors:  Shehroo B Pudumjee; Emily S Lundt; Sabrina M Albertson; Mary M Machulda; Walter K Kremers; Clifford R Jack; David S Knopman; Ronald C Petersen; Michelle M Mielke; Nikki H Stricker
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.